These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33204074)

  • 1. Patient-Reported Outcomes and Impact of Type 2 Diabetes: A Cross-Sectional Study in the Kingdom of Saudi Arabia.
    Gelhorn HL; Boye KS; Shalhoub H; Matza LS; Jordan JB; Alhammad A; Anand SB; Ekhzaimy AA; Strizek A
    Patient Prefer Adherence; 2020; 14():2231-2242. PubMed ID: 33204074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Health-Related Quality of Life of Patients with Type 2 Diabetes in Saudi Arabia.
    AbuAlhommos AK; Alturaifi AH; Al-Bin Hamdhah AM; Al-Ramadhan HH; Al Ali ZA; Al Nasser HJ
    Patient Prefer Adherence; 2022; 16():1233-1245. PubMed ID: 35586578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-Like Peptide-1 Receptor Agonist Utilization in Type 2 Diabetes in Japan: A Retrospective Database Analysis (JDDM 57).
    Ishigaki Y; Strizek A; Aranishi T; Arai N; Imaoka T; Cai Z; Maegawa H
    Diabetes Ther; 2021 Jan; 12(1):345-361. PubMed ID: 33300091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the EQ-5D in the Middle East: A Systematic Review Focusing on Patients Living in the Kingdom of Saudi Arabia.
    Althemery A
    J Multidiscip Healthc; 2021; 14():1101-1106. PubMed ID: 34012267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mobile diabetes management and educational system for type-2 diabetics in Saudi Arabia (SAED).
    Alotaibi MM; Istepanian R; Philip N
    Mhealth; 2016; 2():33. PubMed ID: 28293606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' preferences for once-daily oral versus once-weekly injectable diabetes medications: The REVISE study.
    Boye K; Ross M; Mody R; Konig M; Gelhorn H
    Diabetes Obes Metab; 2021 Feb; 23(2):508-519. PubMed ID: 33140575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preference for Oral and Injectable GLP-1 RA Therapy Profiles in Japanese Patients with Type 2 Diabetes: A Discrete Choice Experiment.
    Igarashi A; Bekker Hansen B; Langer J; Tavella F; Collings H; Davies N; Wyn R
    Adv Ther; 2021 Jan; 38(1):721-738. PubMed ID: 33245530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes Distress Among Adults With Type 1 Diabetes Mellitus in Saudi Arabia.
    Aljohani AA; Almoghamsi EY; Alzaman N; Alharbi MB; Bin Faidh AJ
    Cureus; 2023 Apr; 15(4):e37525. PubMed ID: 37193469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of diabetic peripheral neuropathy among type II diabetic patients in King Fahd University Hospital, Khobar, Kingdom of Saudi Arabia.
    Jatooi NA; Alsulaiman ASA; Alromaih NJ; Abdullah Albahrani B; Alkhattaf IM; Alyami F; Alabdrabalrasol KA
    Hosp Pract (1995); 2021 Apr; 49(2):63-70. PubMed ID: 33216654
    [No Abstract]   [Full Text] [Related]  

  • 10. Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective.
    Whalley D; Globe G; Crawford R; Doward L; Tafesse E; Brazier J; Price D
    Health Qual Life Outcomes; 2018 Aug; 16(1):160. PubMed ID: 30075729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient perceptions of injection devices used with dulaglutide and liraglutide for treatment of type 2 diabetes.
    Matza LS; Boye KS; Currie BM; Paczkowski R; Lando LF; Mody R; Jordan J
    Curr Med Res Opin; 2018 Aug; 34(8):1457-1464. PubMed ID: 29661026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in Indonesian type 2 diabetes mellitus outpatients measured with the Bahasa version of EQ-5D.
    Arifin B; Idrus LR; van Asselt ADI; Purba FD; Perwitasari DA; Thobari JA; Cao Q; Krabbe PFM; Postma MJ
    Qual Life Res; 2019 May; 28(5):1179-1190. PubMed ID: 30649698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Self-Management Care and Glycated Hemoglobin Levels Among Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study From the Kingdom of Saudi Arabia.
    Alshahri BK; Bamashmoos M; Alnaimi MI; Alsayil S; Basaqer S; Al-Hariri MT; Vallaba Doss CA
    Cureus; 2020 Dec; 12(12):e11925. PubMed ID: 33304711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of diabetes mellitus on health-related quality of life in Saudi Arabia.
    Almasri DM; Noor AO; Ghoneim RH; Bagalagel AA; Almetwazi M; Baghlaf NA; Hamdi EA
    Saudi Pharm J; 2020 Dec; 28(12):1514-1519. PubMed ID: 33424245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Assessment of the 10-Year Risk of Developing Type 2 Diabetes Among Saudi Adults Based on the Finnish Diabetes Risk Score.
    Elshebiny A; Alrashed A; Albuwaydi Z; Aljassim S; Alhammad F; Alhajji R
    Cureus; 2022 Nov; 14(11):e32034. PubMed ID: 36465216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life of patients with type 2 diabetes mellitus at a tertiary care hospital in Ethiopia.
    Gebremariam GT; Biratu S; Alemayehu M; Welie AG; Beyene K; Sander B; Gebretekle GB
    PLoS One; 2022; 17(2):e0264199. PubMed ID: 35180266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients.
    Pan CW; Sun HP; Wang X; Ma Q; Xu Y; Luo N; Wang P
    Qual Life Res; 2015 Jul; 24(7):1767-74. PubMed ID: 25540029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom.
    Qin L; Chen S; Flood E; Shaunik A; Romero B; de la Cruz M; Alvarez C; Grandy S
    Diabetes Ther; 2017 Apr; 8(2):335-353. PubMed ID: 28236271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EQ-5D-5L is More Discriminative Than the EQ-5D-3L in Patients with Diabetes in Singapore.
    Wang P; Luo N; Tai ES; Thumboo J
    Value Health Reg Issues; 2016 May; 9():57-62. PubMed ID: 27881260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.